K P van Kessel
Overview
Explore the profile of K P van Kessel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
785
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Antal-Szalmas P, Szollosi I, Lakos G, Kiss E, Csipo I, Sumegi A, et al.
Cytometry
. 2001 Oct;
45(2):115-23.
PMID: 11590623
Background: CD14, the major lipopolysaccharide (LPS)-binding protein of myeloid cells, is found as a soluble molecule in human serum. Recent data describe the presence of elevated soluble CD14 (sCD14) concentration...
2.
van Leeuwen H, van Beek A, Dallinga-Thie G, Van Strijp J, Verhoef J, van Kessel K
Neth J Med
. 2001 Oct;
59(3):102-10.
PMID: 11583825
No abstract available.
3.
Peschel A, JACK R, Otto M, Collins L, Staubitz P, Nicholson G, et al.
J Exp Med
. 2001 May;
193(9):1067-76.
PMID: 11342591
Defensins, antimicrobial peptides of the innate immune system, protect human mucosal epithelia and skin against microbial infections and are produced in large amounts by neutrophils. The bacterial pathogen Staphylococcus aureus...
4.
Geerlings S, Brouwer E, van Kessel K, Gaastra W, Hoepelman A
Adv Exp Med Biol
. 2000 Dec;
485:255-62.
PMID: 11109114
No abstract available.
5.
Antal-Szalmas P, Poppelier M, Broekhuizen R, Verhoef J, Van Strijp J, van Kessel K
Cytometry
. 2000 Nov;
41(4):279-88.
PMID: 11084613
Background: CD14 is considered to be the major endotoxin (lipopolysaccharide [LPS]) binding molecule on human monocytes. It initiates cellular response, but its role in the clearance of LPS is not...
6.
Veldkamp K, Heezius H, Verhoef J, Van Strijp J, van Kessel K
Infect Immun
. 2000 Sep;
68(10):5908-13.
PMID: 10992501
In a previous study, we showed that Staphylococcus aureus supernate (SaS) is a potent agonist for both neutrophils and mononuclear cells. To further investigate the immunomodulating effects of SaS, the...
7.
de Haas C, van Leeuwen H, Verhoef J, van Kessel K, Van Strijp J
J Immunol Methods
. 2000 Sep;
242(1-2):79-89.
PMID: 10986391
Lipopolysaccharide (LPS)-binding components in serum play an important role in modifying LPS toxicity. We analyzed the binding characteristics of LPS in the presence of serum using gel filtration of FITC-labeled...
8.
de Haas C, Poppelier M, van Kessel K, Van Strijp J
Infect Immun
. 2000 Aug;
68(9):4954-60.
PMID: 10948110
Lipopolysaccharide (LPS) is an amphipathic macromolecule that is highly aggregated in aqueous preparations. LPS-binding protein (LBP) catalyzes the transfer of single LPS molecules, segregated from an LPS aggregate, to high-density...
9.
de Haas C, van Leeuwen E, van Bommel T, Verhoef J, van Kessel K, Van Strijp J
Infect Immun
. 2000 Mar;
68(4):1753-9.
PMID: 10722560
Although serum amyloid P component (SAP) is known to bind many ligands, its biological function is not yet clear. Recently, it was demonstrated that SAP binds to lipopolysaccharide (LPS). In...
10.
de Haas C, van der Zee R, van Kessel K, Verhoef J, Van Strijp J
Infect Immun
. 1999 May;
67(6):2790-6.
PMID: 10338482
Lipopolysaccharide (LPS) is the major mediator of gram-negative septic shock. Molecules that bind LPS and neutralize its toxic effects could have important clinical applications. We showed that serum amyloid P...